CAE (TSE:CAE) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says

CAE (TSE:CAE) (NYSE:CAE) had its price target increased by Canaccord Genuity Group from C$28.00 to C$30.00 in a research note issued to investors on Thursday morning,BayStreet.CA reports.

Other analysts have also recently issued research reports about the company. National Bankshares lifted their price objective on CAE from C$30.00 to C$34.00 in a research report on Wednesday, November 13th. Scotiabank boosted their price target on CAE from C$30.00 to C$32.50 in a research report on Thursday. BMO Capital Markets lowered their price target on CAE from C$34.00 to C$33.00 in a report on Thursday, July 18th. Desjardins lowered their target price on shares of CAE from C$29.00 to C$28.00 and set a “hold” rating on the stock in a research note on Wednesday, July 17th. Finally, Royal Bank of Canada lifted their price objective on CAE from C$27.00 to C$34.00 in a research note on Thursday. One investment analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, CAE currently has an average rating of “Hold” and a consensus target price of C$32.35.

CAE Price Performance

TSE CAE opened at C$30.67 on Thursday. The firm has a market capitalization of C$9.78 billion, a price-to-earnings ratio of -28.66, a price-to-earnings-growth ratio of 1.76 and a beta of 1.91. The company has a debt-to-equity ratio of 74.24, a current ratio of 0.89 and a quick ratio of 0.71. The company has a 50 day simple moving average of C$25.49 and a 200-day simple moving average of C$25.49. CAE has a 52-week low of C$22.28 and a 52-week high of C$31.08.

CAE Company Profile

CAE Inc, together with its subsidiaries, provides simulation training and critical operations support solutions in Canada, the United States, the United Kingdom, Europe, Asia, Oceania and Africa, and Rest of Americas. It operates through three segments: Civil Aviation, Defense and Security, and Healthcare.